Search results for "survival analysi"

showing 10 items of 752 documents

Relation of Multiple Inflammatory Biomarkers to Incident Atrial Fibrillation

2009

Basic and clinical studies have suggested that inflammation predisposes to atrial fibrillation (AF). We assessed the association of 12 circulating inflammatory biomarkers (i.e., C-reactive protein, fibrinogen, interleukin-6, intercellular adhesion molecule-1, lipoprotein-associated phospholipase A2 [mass and activity], monocyte chemoattractant protein-1, myeloperoxidase, CD40 ligand, osteoprotegerin, P-selectin, and tumor necrosis factor receptor II) with incident AF in 2863 Framingham Offspring Study participants (mean age 60.7 years, SD = 9.4, 55% women). During follow-up (median 6 years), 148 participants (43% women) developed incident AF. In the multivariable proportional hazards models…

Malemedicine.medical_specialtyHeart diseaseArticleOsteoprotegerinRisk FactorsInternal medicineGermanyAtrial FibrillationConfidence IntervalsOdds RatioMedicineHumansMyocardial infarctionProspective StudiesInflammationFramingham Risk Scorebusiness.industryProportional hazards modelIncidenceHazard ratioOsteoprotegerinAtrial fibrillationMiddle Agedmedicine.diseaseSurvival AnalysisConfidence intervalC-Reactive ProteinMultivariate AnalysisCardiologyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkers
researchProduct

Biochemical risk indices, including plasma homocysteine, that prospectively predict mortality in older British people: the National Diet and Nutritio…

2010

Predictive power, for total and vascular mortality, of selected indices measured at baseline in the British National Diet and Nutrition Survey (community-living subset) of People Aged 65 Years and Over was tested. Mortality status and its primary and underlying causes were recorded for 1100 (mean age 76·7 (sd7·5) years, 50·2 % females) respondents from the baseline survey in 1994–5 until September 2008. Follow-up data analyses focussed especially on known predictors of vascular disease risk, together with intakes and status indices of selected nutrients known to affect, or to be affected by, these predictors. Total mortality was significantly predicted by hazard ratios of baseline plasma co…

Malemedicine.medical_specialtyHomocysteineMedicine (miscellaneous)Nutritional StatusDiet SurveysArticlechemistry.chemical_compoundRisk FactorsInternal medicineMedicineChymotrypsinHumansVitamin B12Vascular DiseasesRisk factorMortalityHomocysteineSurvival analysisAgedProportional Hazards ModelsAged 80 and overGlycated HemoglobinCreatinineNutrition and Dieteticsbusiness.industryProportional hazards modelHazard ratioFibrinogenPrognosisSurvival AnalysisUnited KingdomB vitaminsEndocrinologyCholesterolchemistryCreatinineVitamin B ComplexFemaleDietary ProteinsbusinessEnergy IntakeBiomarkersDemographyThe British journal of nutrition
researchProduct

Deep sclerectomy versus punch trabeculectomy with or without phacoemulsification: a randomized clinical trial.

2004

Purpose: To compare the efficacy of non-penetrating deep sclerectomy without implant with Crozafon-De Laage punch trabeculectomy, and to evaluate the effect of simultaneous temporal approach phacoemulsification on both techniques. Patients and Methods: Setting: Department of Ophthalmology of the University of Palermo. Design: Prospective randomized clinical trial. Patients and intervention procedures: Sixty-five patients (65 eyes) with primary open angle glaucoma (POAG) or pseudoexfoliative glaucoma (PEXG): 32 eyes underwent non-penetrating deep sclerectomy (NPDS), 17 as single procedure and 15 combined with phacoemulsification (phaco- NPDS), and 33 eyes underwent punch trabeculectomy (PT),…

Malemedicine.medical_specialtyIntraocular pressuremedicine.medical_treatmentGlaucomaTrabeculectomyExfoliation SyndromeDeep sclerectomylaw.inventionRandomized controlled triallawOphthalmologymedicineTrabeculectomyHumansProspective Studiespunch trabeculectomyIntraocular PressureAgedPhacoemulsificationSettore MED/30 - Malattie Apparato Visivobusiness.industrydeep sclerectomyPhacoemulsificationrandomized clinical trialmedicine.diseaseSurvival AnalysisClinical trialOphthalmologyTreatment OutcomeSclerostomyFemaleImplantbusinessGlaucoma Open-AngleJournal of glaucoma
researchProduct

Efficacy and safety of yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for auto…

2007

A prospective, multicenter, nonrandomized phase 2 trial was conducted to evaluate the efficacy and safety of a single dose of yttrium-90 (90Y) ibritumomab tiuxetan in elderly patients in first relapsed or primary refractory diffuse large B-cell lymphoma (DLBCL) ineligible for stem-cell transplantation. Patients had been previously treated with chemotherapy (group A, n = 76) or chemotherapy plus rituximab (group B, n = 28). Patients in group A were further divided into patients in whom induction therapy had failed (stratum AI, n = 33) and patients who had relapsed after achieving complete response (CR; stratum AII, n = 43). The overall response rate (ORR) was 52% and 53% in strata AI and AII…

Malemedicine.medical_specialtyLymphoma B-Cellmedicine.medical_treatmentImmunologyIbritumomab tiuxetanSalvage therapyAuthor Keywords:RadioimmunotherapyBiochemistryGastroenterologyAntibodies Monoclonal Murine-DerivedTRIAL Author InformationAutologous stem-cell transplantationRecurrenceInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineRefractory Diffuse Large B-Cell LymphomaHumansYttrium RadioisotopesY-90-ibritumomab tiuxetanHematologic toxicity KeyWords Plus:B-CELL LYMPHOMAAuthor Keywords:Radioimmunotherapy; Y-90-ibritumomab tiuxetan; Hematologic toxicity KeyWords Plus:B-CELL LYMPHOMA; LOW-GRADE; RADIOIMMUNOTHERAPY; INDOLENT; TRIAL Author InformationAgedCerebral HemorrhageAged 80 and overSalvage TherapyChemotherapybusiness.industryRemission InductionAntibodies MonoclonalCell BiologyHematologyRADIOIMMUNOTHERAPYINDOLENTmedicine.diseaseSurvival AnalysisLOW-GRADESurgeryTransplantationRituximabFemaleLymphoma Large B-Cell DiffusebusinessRituximabDiffuse large B-cell lymphomamedicine.drug
researchProduct

Radiomics analysis of 18F-Choline PET/CT in the prediction of disease outcome in high-risk prostate cancer: an explorative study on machine learning …

2021

Objective: The aim of this study was (1) to investigate the application of texture analysis of choline PET/CT images in prostate cancer (PCa) patients and (2) to propose a machine-learning radiomics model able to select PET features predictive of disease progression in PCa patients with a same high-risk class at restaging. Material and methods: Ninety-four high-risk PCa patients who underwent restaging Cho-PET/CT were analyzed. Follow-up data were recorded for a minimum of 13 months after the PET/CT scan. PET images were imported in LIFEx toolbox to extract 51 features from each lesion. A statistical system based on correlation matrix and point-biserial-correlation coefficient has been impl…

Malemedicine.medical_specialtyMachine learningcomputer.software_genre030218 nuclear medicine & medical imagingCholineCorrelationMachine Learning03 medical and health sciences0302 clinical medicineArtificial IntelligencePositron Emission Tomography Computed TomographymedicineHumansRadiology Nuclear Medicine and imagingCholine; Machine learning; Positron emission tomography computed tomography; Prostate cancer; Radiomics.Prospective StudiesEntropy (energy dispersal)Prospective cohort studySurvival analysisPET-CTbusiness.industryProstatic NeoplasmsGeneral MedicineLinear discriminant analysismedicine.diseasePrimary tumorFeature (computer vision)030220 oncology & carcinogenesisRadiologyArtificial intelligenceNeoplasm Recurrence LocalbusinesscomputerMachine learning Positron emission tomography computed tomography Prostate cancer Radiomics Artificial Intelligence
researchProduct

Assessment of morphological CT imaging features for the prediction of risk stratification, mutations, and prognosis of gastrointestinal stromal tumors

2021

To investigate the correlation between CT imaging features and risk stratification of gastrointestinal stromal tumors (GISTs), prediction of mutation status, and prognosis. This retrospective dual-institution study included patients with pathologically proven GISTs meeting the following criteria: (i) preoperative contrast-enhanced CT performed between 2008 and 2019; (ii) no treatments before imaging; (iii) available pathological analysis. Tumor risk stratification was determined according to the National Institutes of Health (NIH) 2008 criteria. Two readers evaluated the CT features, including enhancement patterns and tumor characteristics in a blinded fashion. The differences in distributi…

Malemedicine.medical_specialtyMultivariate analysisGastrointestinal Stromal TumorsPopulationX-ray computedRisk Assessment030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinemedicineHumansRadiology Nuclear Medicine and imagingProgression-free survivaleducationPathologicalTomographySurvival analysisGastrointestinal stromal tumors; Mutation; Progression-free survival; Survival analysis; Tomography X-ray computed; Aged; Female; Humans; Male; Middle Aged; Mutation; Prognosis; Retrospective Studies; Risk Assessment; Tomography X-Ray Computed; Gastrointestinal Stromal TumorsNeuroradiologyAgedRetrospective Studieseducation.field_of_studybusiness.industryProportional hazards modelTomography X-ray computedHazard ratioProgression-free survivalGeneral MedicineSurvival analysisMiddle AgedPrognosis030220 oncology & carcinogenesisMutationFemaleRadiologyGastrointestinal stromal tumors Mutation Progression-free survival Survival analysis Tomography X-ray computedbusiness
researchProduct

Parkinson disease survival: a population-based study

2000

Objective To evaluate whether the survival of patients with Parkinson disease (PD) is shorter than that of the general population. Design Survival was investigated in a cohort of patients with PD previously identified during a population-based prevalence study (prevalence day, November 1, 1987; reference follow-up date, October 31, 1995). The survival of patients with PD was compared with that of a control sample randomly selected from the same population (2 controls for each case, matched for age, sex, and study municipality). The causes of death in the 2 groups were also compared. Both univariate and multivariate survival analyses were performed to investigate the association with disease…

Malemedicine.medical_specialtyMultivariate analysisHeart DiseasesPopulationComorbidityCohort StudiesLevodopaAge DistributionArts and Humanities (miscellaneous)Internal medicineCause of DeathmedicinePrevalenceHumansSex DistributioneducationSurvival rateSicilySurvival analysisCause of deathAgedProportional Hazards ModelsAged 80 and overUnivariate analysiseducation.field_of_studyNeuroscience (all)Proportional hazards modelbusiness.industryParkinson DiseasePneumoniaMiddle AgedSurvival AnalysisSurgerySurvival RateMultivariate AnalysisSettore MED/26 - NeurologiaFemaleNeurology (clinical)businessCohort study
researchProduct

Natural history of the Sprint Fidelis lead: survival analysis from a large single-center study.

2012

The purposes of our study were to: (1) determine lead failure rate in a large single-center cohort of Sprint Fidelis 6949 (Fidelis) leads, (2) define the risk of lead failure over time, (3) assess the impact of the Lead Integrity Alert (LIA) on lead failure presentation, and (4) identify independent predictors of Fidelis lead failure. All patients who underwent implantation of a Fidelis lead between September 2004 and July 2007 were included. Demographic, clinical, and device characteristics at the time of implant and prior to failure were collected and analyzed. A total of 971 Fidelis leads (706 men, 265 women, mean age 68.4 ± 12.8 years) were implanted. Over a mean follow-up of 46.3 month…

Malemedicine.medical_specialtyMultivariate analysisSingle CenterRisk AssessmentSprint fidelis leadRisk FactorsPhysiology (medical)Internal medicinemedicinePrevalenceHumansLead (electronics)Survival rateSurvival analysisAgedHeart Failurebusiness.industryIncidence (epidemiology)Survival AnalysisSettore MED/11 - Malattie Dell'Apparato CardiovascolareDefibrillators ImplantableElectrodes ImplantedSurvival RateConnecticutTreatment OutcomeCohortCardiologyEquipment FailureFemaleCardiology and Cardiovascular MedicineRisk assessmentbusiness
researchProduct

Prognostication of post-infarct chronic heart failure: superiority of clinical assessment vs. cardiopulmonary and left ventricular function analysis.

2009

Prognostication of congestive heart failure post-myocardial infarction (MI) is important for decision making. We sought of a head-to-head comparison between the prognostic implication of clinical, cardiopulmonary, and left ventricular (LV) function assessment.Retrospectively, 100 consecutive post-MI patients (MI history 1418+/-1668 days ago) were stratified by NYHA functional classification system, cardiopulmonary exercise testing (CPX) [oxygen consumption at maximal exercise (VO(2max)) and at the anaerobic threshold (VO(2AT)) resulting in the Weber classification], and LV function analysis by M-mode and two-dimensional echocardiography [LV end-diastolic and -systolic diameter index (LVDDI …

Malemedicine.medical_specialtyMyocardial InfarctionInfarctionPhysical exerciseVentricular Function LeftInternal medicinemedicineHumansMyocardial infarctionSurvival analysisEnd-systolic volumeAgedRetrospective StudiesHeart FailureEjection fractionbusiness.industryMiddle Agedmedicine.diseasePrognosisSurvival RateHeart failureChronic DiseaseHeart Function TestsCardiologyFemaleCardiology and Cardiovascular MedicinebusinessAnaerobic exerciseInternational journal of cardiology
researchProduct

Clinical profile of motor neuron disease patients with lower urinary tract symptoms and neurogenic bladder

2017

Introduction: Lower urinary tract symptoms (LUTS) are frequent in motor neuron disease (MND) patients, but clinical factors related to them are unknown. We describe differences in LUTS among MND phenotypes and their relationship with other clinical characteristics, including prognosis. Methods: For this study, we collected clinical data of a previously published cohort of patients diagnosed with classical amyotrophic lateral sclerosis (cALS), progressive muscular atrophy (PMA) or primary lateral sclerosis (PLS) with and without LUTS. Familial history was recorded and the C9ORF72 expansion was analysed in the entire cohort Patients were followed-up for survival until August 2016. Results: Fi…

Malemedicine.medical_specialtyNeurogenic bladder030232 urology & nephrologyDiseaseMuscular Atrophy Spinal03 medical and health sciencesSex Factors0302 clinical medicineLower Urinary Tract SymptomsLower urinary tract symptomsC9orf72Primary lateral sclerosisInternal medicinemedicineHumansLower urinary tract symptomsMotor neuron diseaseMotor Neuron DiseaseUrinary Bladder NeurogenicFamily historyAmyotrophic lateral sclerosisAgedPrimary Lateral SclerosisC9orf72 Proteinbusiness.industryAmyotrophic Lateral SclerosisMiddle AgedProgressive muscular atrophyPrognosismedicine.diseaseAmyotrophic lateral sclerosisSurvival AnalysisSurgeryUrodynamicsCross-Sectional StudiesPhenotypeNeurologyProgressive muscular atrophyAmyotrophic lateral sclerosis Lower urinary tract symptoms Motor neuron disease Neurogenic bladder Primary lateral sclerosis Progressive muscular atrophy UrodynamicsMultivariate AnalysisCohortFemaleNeurology (clinical)business030217 neurology & neurosurgeryFollow-Up Studies
researchProduct